RGAHX
Price
$71.62
Change
-$0.09 (-0.13%)
Updated
May 9 closing price
Net Assets
285.48B
VAFRX
Price
$25.40
Change
-$0.09 (-0.35%)
Updated
May 9 closing price
Net Assets
15.19B
Ad is loading...

RGAHX vs VAFRX

Header iconRGAHX vs VAFRX Comparison
Open Charts RGAHX vs VAFRXBanner chart's image
American Funds Growth Fund of Amer R5E
Price$71.62
Change-$0.09 (-0.13%)
VolumeN/A
Net Assets285.48B
Invesco American Franchise R
Price$25.40
Change-$0.09 (-0.35%)
VolumeN/A
Net Assets15.19B
RGAHX vs VAFRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RGAHX vs. VAFRX commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGAHX is a StrongBuy and VAFRX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 285B vs. VAFRX (15.2B). RGAHX pays higher dividends than VAFRX: RGAHX (0.54) vs VAFRX (0.00). RGAHX was incepted earlier than VAFRX: RGAHX (9 years) vs VAFRX (14 years). VAFRX (1.21) is less costly to investors than RGAHX (0.44). VAFRX is a more actively managed with annual turnover of: 51.00 vs. RGAHX (25.00). RGAHX has a lower initial minimum investment than VAFRX: RGAHX (250) vs VAFRX (1000). VAFRX annual gain was more profitable for investors over the last year : 4.35 vs. RGAHX (3.25). RGAHX return over 5 years is better than : 44.87 vs. VAFRX (16.89).
RGAHXVAFRXRGAHX / VAFRX
Total Expense Ratio0.441.2136%
Annual Report Gross Expense Ratio0.441.2136%
Fund Existence9 years14 years-
Gain YTD-2.478-8.17130%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets285B15.2B1,875%
Annual Yield % from dividends0.540.00-
Returns for 1 year3.254.3575%
Returns for 3 years33.4040.1883%
Returns for 5 years44.8716.89266%
Returns for 10 yearsN/A49.41-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARKO4.770.32
+7.19%
ARKO Corp
LYRA0.10N/A
+4.03%
Lyra Therapeutics
JJSF116.230.49
+0.42%
J & J Snack Foods Corp
CRL138.79-2.57
-1.82%
Charles River Laboratories International
FDMT3.08-0.16
-4.94%
4D Molecular Therapeutics